Ranjan Banerjee

Ranjan Banerjee is a highly experienced professional in the field of chemistry and drug development, currently serving as Senior Director of CMC at Axsome Therapeutics, Inc. since June 2021, focusing on drug substance chemical development, manufacturing science and technology, regulatory CMC, and analytical sciences. Prior roles include Director of CMC at Axsome Therapeutics, Associate Director of CMC at Constellation Pharmaceuticals, Senior Scientist at Merck, and CMC Manager at Boston Biomedical, where responsibilities encompassed external manufacturing, drug development, and regulatory applications. Ranjan Banerjee's career began as a Research Scientist at Boston Biomedical and included a Postdoctoral Research Associate position at Boston College, demonstrating a robust background in both applied and theoretical chemistry. Ranjan Banerjee holds a Ph.D. in Organic Chemistry from Wake Forest University, a Master of Science in Chemistry from the Indian Institute of Technology, Kharagpur, and a Bachelor of Science in Chemistry from the University of Calcutta.